Project BioShield loses supplier for vaccine

摘要

The US government has cancelled the biggest and most visible contract under its $5.6-billion Project BioShield programme, telling a small California company that it failed to make agreed progress in developing an anthrax vaccine for civilian biodefence. The cancellation last month leaves the government without a major supplier of next-generation vaccine. Michael Leavitt, the government's secretary of health and human services, said he would make finding one "a priority".